Stereotactic arrhythmia radioablation reduces sustained ventricular tachycardia episodes and defibrillator shocks in patients with treatment-refractory disease, without treatment related deaths.
In the single-arm FULCRUM-VT trial, 59% of patients remained free of recurrent VT at 6 months, with less amiodarone use.
Adagio Medical Holdings, Inc. ADGM shares are up during Monday’s premarket session following the announcement of positive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results